Paradigm BiopharmaceuticalsPAR 
$0.16-4.08%24h
-4.08%24h
Global rank24580
Market cap$46.05M
Change 7d-6.00%
YTD Performance-46.59%
SP500 benchmarkUnderperform
P/E-0.89
P/S1455.83
Revenue$31.63K
Earnings-$35.12M
Dividend yield-
Main Sector
Healthcare
Paradigm Biopharmaceuticals (PAR) Total Liabilities
PAR Total Liabilities in 2022: $9.06M
According to Paradigm Biopharmaceuticals latest financial reports the total liabilities of PAR is $9.06M, an increase of 59.88% to 2022. At the end of 2022 company had $5.67M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Paradigm Biopharmaceuticals is responsible for during its operational activities.
Paradigm Biopharmaceuticals (PAR) Total Liabilities History from 2023 to 2022
-
Value:-
PAR Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $9.06M | 59.88% |
| 2022 | $5.67M | 28.49% |
| 2021 | $4.41M | 55.88% |
| 2020 | $2.83M | 83.47% |
| 2019 | $1.54M | - |
View the Top Total Liabilies Stocks
